AKT1 and Miyoshi myopathy: It has been shown that in MM cell lines, C6-ceramid increased the exosomal level of antitumor miRNAs, including miR-29b, miR-202, and miR-15a/16 [144], which simultaneously exerted anti-angiogenesis and antitumorigenesis effects by targeting the Akt pathways [143].